Sunteți pe pagina 1din 12

ENDOCRINE PART 2

ANTERIOR (PITUITARY)
1. Growth hormone
2. Prolactin
3. Thyrotropic
4. Adrenocorticotropic
5. Gonadotropic hormones PITUITARY DWARFISM

GROWTH HORMONE
 Effects is directed to the growth of
skeletal muscles and long bones of
the body
 Hyposecretion: pituitary dwarfism
(adult height of 4 feet)
 Hypersecretion: gigantism (8-9 feet)
 Acromegaly – occurs after long bone
GIGANTISM
growth has ended, particularly the
lower jaw and the bony ridges INCREASE SECRETION OF GROWTH
HORMONE
ABNORMALITIES ASSOCIATED WITH
GROWTH HORMONE  Short life span leading to suffer
hyperglycemia and ketosis due to
 Decrease secretion: before puberty metabolic effects of hormones
 Before puberty – giantism
 Pituitary dwarfism – no growth
 After puberty – Acromegaly – lateral
hormone receptor, abnormal growth growth, spade like hands & feet
of cartilage  Prognantism - enlargement of jaw or
 Cretinism – normal growth hormone mandible
levels but thyroid hormone is deficient  Macroglasia – enlargement of the
(ugly dwarf – cretin) tongue

Cretinism
ACROMEGALY MELANOCYTE STIMULATING HORMONE
PROLACTIN  MSH may resemble ACTH and
responsible for the darkening and
 Known target in human is the breast pigmentation of the skin (Addison’s
 After birth, it stimulates and maintains disease & Nelson’s disease since
milk production by the mother’s breast there is hypersecretion of ACTH)
 Target cells are the melanocyte

Wonders of Melanocyte Stimulating


Hormone

ADRENOCORTICOTROPHIC HORMONE
(ACTH)

 Regulates the endocrine activity of


the cortex portion of the adrenal gland
GONADOTROPIC HORMONES  A lobe in the forebrain, secretes
melatonin hormone
LUTEINIZING HORMONE  In mammals, the amount of light
influence the pineal’s secretion of
 Luteinizing Hormone (LH, also melatonin in an inverse relationship,
known as lutropin) is a hormone the more light the less melatonin
produced by the anterior pituitary  Melatonin, in turn inhibits the release
gland. of gonadotrophic hormones.
 In the female, an acute rise of LH –
the LH surge – triggers ovulation THYROID GLAND
 In the male, where LH had also been
called Interstitial Cell Stimulating  Located in front of and each side of
Hormone (ICSH), it stimulates Leydig the thyroid cartilage of the larynx
cell production of testosterone  The hormone stimulates general
metabolism & growth
FSH  Increase in sensitivity of various
 Follicle – stimulating Hormone organs especially the CNS
(FSH) is a hormone synthesized and  Has pronounced effect on the change
secreted by gonadotropes in the from infertile to adult form
anterior pituitary gland  Controlled by anterior lobe of the
 FSH regulates the development, pituitary
growth, pubertal maturation and
reproductive processes of the human
body
 FSH and Luteinizing Hormone (LH)
act synergistically in reproduction.

PINEAL GLAND

ANATOMY
 Consists of 2 lobes located in the
lower part of the neck
 Lobes are connected by a narrow
band called isthmus (right lobe
larger than left)
 Lobes weigh 20-30 g each
measuring 4.0 cm. In length and 2
cm to 2.5 cm in width
 2 types of cells are follicular – Majority of circulating hormone is T4
(cuboidal) & perifollicular cells  98.5% of T4
 Follicular cells are secretory &  1.5% of T3
produce thyroxine (T4) and
triiodothyronine (T3) – Total Hormone load is influenced by
serum binding proteins (TBP,
COLLOID MATRIX - THYROGLOBULIN Albumin??)
 Thyroid Binding
Globulin 70%
 Albumin 15%
 Transthyretin 10%

– Regulation is based on the free


component of thyroid hormone

FEEDBACK REGULATION THE


 The perifollicular cells or C cells HYPOTHALMIC – PITUITARY – THYROID
are situated in clusters along AXIS
interfollicular or C cells
 C cells produce Calcitonin - involve  Hormones derived from the pituitary
in calcium regulation that regulate the synthesis and/or
secretion of other hormones are
THYROID HORMONE known as trophic hormones.
 Key players for the thyroid include:

1. TRH – Thyrophin Releasing


Hormone
2. TSH – Thyroid Stimulating
Hormone
3. T4/T3 – Thyroid Hormones

Thyroid Hormone Control


THYROID (CONT.)  T3 - contains 2 iodine atoms in the
tyrosyl ring and one iodine atom in
 Regulates basal metabolic rate phenolic ring
 Improves cardiac contractility  rT3 – contains 2 iodine atom in the
 Increases the gain of catecholamines phenolic ring and one iodine atom
 Increases bowel motility in the tyrosyl ring.
 Increases speed of muscle  2 DIT molecules = T4 (thyroxine”)
contraction 50% greater than T3 and bound to
 Decreases cholesterol (LDL) serum proteins
 Required for proper fetal neural  Most iodothyronine (T3 & T4) are
growth secreted directly in the blood stream
while iodothyrosines (MIT and DIT)
BIOSYNTHESIS, TRANSPORT, AND are deiodinated within the thyroid and
ACTION the iodide is used in producing
iodoamino acids.
 Iodine is the most important element
in the biosynthesis of thyroid TSH REGULATION OF THYROID
hormones FUNCTION
 Thyroid gland traps iodide 70
mg/day for active transport.  TSH binds to specific cell
 Iodide is then transported to the surface receptors that
follicular lumen stimulate adenylate cyclase
 Iodide molecule is oxidized by to produce cAMP.
perioxidase and transform into  TSH increases metabolic
reactive form I0 or I + and combine activity that is required to
with glycoprotein thyroglobulin synthesize Thyroglobulin (Tg)
(thyroid follicle) and generate peroxide.
 Thyroglobulin acts as matrix  TSH stimulates both I- uptake
containing tyrosyl group to which and iodination of tyrosine
iodine attaches to form resides on Tg.
 Monoidotyrosine (MIT) and ION TRANSPORT BY THE THYROID
Diiodotyrosine (DIT) FOLLICULAR CELL
 Next step is the enzymatic coupling
of the iodinated tyrosine molecules
catalyzed by peroxidase to form T4 or
T3.
 1 DIT + 1 MIT = T3 (3,5,3’
triiodothyronine or reverse T3 (rT3)
(3,3’,5’ triiodothyronine) which is
form from peripheral deiodination of
T4.
THYROGLOBULIN SYNTHESIS IN THE THYROID PHYSIOLOGY
THYROID FOLLICULAR CELL  Uptake of iodine by the thyroid
 Coupling of iodine to Thyroglobulin
 Storage of MIT / DIT in follicular
space
 Re-absorption of MIT / DIT
 Formation of T3, T4 from MIT/DIT
 Release of T3, T4 into serum
 Breakdown of T3, T4 with release of
Iodine

SPECIFIC ACTIONS OF THYROID


HORMONE: METABOLIC

THYROID HORMONES IN THE BLOOD  Regulates of Basal Metabolic


 Approximately 99.98% of T4 is bound Rate (BMR)
to 3 serum proteins: Thyroid Binding  Increases oxygen consumption in
Globulin (TBG) ~ 75%; Thyroid most target tissues.
Binding Prealbumin (TBPA or  Permissive actions: TH increases
transthyretin) 15-20%; Albumin - 5- sensitivity of target tissues to
10% catecholamines, therevy elevating
 Only ~ 0.02% of the total T4 in blood lipolysis, glycogenolysis, and
is unbound or free. gluconeogenesis.
 Only ~ 0.4% of total T3 in blood is free
SPECIFIC ACTIONS OF THYROID
THYROID HORMONE METABOLISM HORMONE: DEVELOPMENT

 TH is critical for normal


development of the skeletal
system and musculature
 TH is also essential for normal
brain development and regulates
synaptogenesis, neuronal
integration, myelination and cell
migration
 Cretinism is the term for the
constellation of defects resulting
from untreated neonatal
hypothyroidism.
EXAMPLES OF THYROID DISEASES  Specimens are collected in clot tube
(red or yellow)
 Not fasting
 Serum separated after clotting but if
delayed refrigerate for 24 hours or
frozen for 30 days
 Specimen are free of lipemia and
hemolysis are preferred.

5 CATEGORIES OF TEST
1. Those that assess the state of the
hypothalamic – pituitary –thyroid axis
2. Estimates of T3 and T4
concentrations in the serum
3. Tests that reflect the impact of thyroid
hormone on tissues
4. Tests for the presence of autoimmune
thyroid disease
5. Tests that provide information about
thyroidal iodine metabolism

 TOTAL THYROXINE (TT4)


 When there is an increase
more T4 will bind resulting
increase TT4
 Decrease results in less
binding sites which decreases
TT4
 Factors: serum concentration
of T4, pregnancy, acute
illnesses or effects of drugs

 THYROID HORMONE RATIO OR T3


UPTAKE (T3U) TEST
 THBR is used to measure the
available binding sites of the
ASSAYS FOR THYROID FUNCTION thyroxine binding proteins
(TBG)
 Assays for thyroid hormones used to  I125, enzyme, fluorophore and
determine and confirm the nature and chemiluminescence labelling
extent of hyperthyroidism or techniques is used.
hypothyroidism
 Serum is mixed with labelled  THYROID RELEASING HORMONE
T3 and a binding material (TRH) STIMULATION TEST –
such as resin. THYROTROPIN RELEASING
HORMONE
 CALCULATED FREE THYROXINE
INDEX (FT4I)  Detects residual TSH stores in the
 TT4 and THBR are test used to pituitary gland
calculate the level of free  Patients with primary hypothyroidism
thyroxine (FT4) would have an increase value
 FT4I - is an indirect measure of  Differentiating between NTI sick and
free hormone concentration and is hyperthyroid patients
based on the equilibrium  Euthyroid patients will respond to
relationship of bound T4 and FT4 TRH whereas hyperthyroid will not
 Useful in correcting euthyroid
individual – Increased TSH
 Adequate indicator thyroid status.
 Primary hypothyroidism
 MEASURED FREE THYROXINE  Hashimoto’s thyroiditis
(FT4)  Thyrotoxicosis due to pituitary
 Most reliable in severe NTI or tumor
susceptible thyroid disease  TSH antibodies
 Specific in differentiating euthyroid  Thyroid Hormone resistance
 Differentiating hyperthyroid from
hypothyroid – Decreased TSH
 Primary hyperthyroidism
 TSH TEST  Secondary and Tertiary
 First and best laboratory test for hypothyroidism
identification of thyroid  Treated Grave’s disease
abnormalities  Euthyroid sick disease
 Most important thyroid function  Over replacement of thyroid hormone
test & screening test in hypothyroidism
 Confirmation of suspected
primary hypothyroidism &  THYROGLOBULIN ASSAY (Tg)
hyperthyroidism and also  Used as post-operative marker of
borderline cases thyroid cancer
 Subclinical hyperthyroidism –  Used in monitoring the course of
abnormal TSH, normal TT4 or metastatic or recurrence of thyroid
FT4 no overt symptoms cancer
 Decreased levels: infants with
goitorous hypothyroidism,
thyrotoxicosis
 Increased: untreated and  THYROID ANTIBODIES
metastatic differentiated thyroid  Thyrotropin receptor (TSHR)
cancer and hyperthyroidism  Thyroperoxidase (TPO) /
antimicrosomal antibodies
 THYROID BINDING PROTEIN (TBG)  Antithyroglobulin antibodies
AND THYROGLOBULIN  Thyroid disease produce
antibodies against thyroid follicles
 Used to measure to confirm
results of FT3 or FT4 or  RADIOACTIVE IODINE UPTAKE
abnormalities in the relationship of (RAIU) AND THYROID SCAN
the TT4 and THBR test
 Thyroglobulin – used as  RAIU – used to measure the
postoperative marker of thyroid ability of the thyroid gland to trap
cancer iodine
 Low level may indicate the  Radioactive iodine – is ingested
presence of thyrotoxicosis by mouth and radioactivity is
counted as various length of time
 TOTAL T3 (TT3) FREE T3 (FT3) (2 – 4 – 6 – 24 hrs)
AND FREE T3 INDEX (FT3I)  Useful in helping to determine the
cause of hyperthyroidism
 T3 levels clinically relates the states
of the patient  THYROID SCAN
 TT3 level or FT3 used to confirm
hyperthyroidism especially in T3  Used to determine the size,
thyrotoxicosis in which TSH is shape, activity of thyroid tissue or
decreased but the FT4I or FT4 is nodules
within normal  An isotope is administered to the
 FT3I= T3 x THBR patient and is taken up by the
thyroid gland and distribution is
 REVERSE T3 (RT3) measured by a scan
 The scan is useful in determining
 Help in the resolution of borderline or hyperthyroidism and extrathyroid
conflicting laboratory results iodide concentrating tissue
 Elevated in patients with NTI in which  Important in Identification of areas
TT3 levels is decreased. where decrease or increase
 Amniotic diagnosis of rT3 is useful uptake within the gland
in diagnosis of fetal hypothyroidism  Nodules as small as 1 cm can be
and thyroiditis detected
1. Cold – non-functioning
2. Hot – hyperfunction
3. Warm – normal functioning
 FINE NEEDLE ASPIRATION physical & mental performance,
 Provide the malignant potential of change in personality, intolerance
thyroid nodule to cold, exertional dyspnea,
hoarseness, constipation,
 RECOMBINANT HUMAN TSH decreased sweating, easy
 Used to patients with thyroid cancers bruising, muscle cramps & dry
for the presence of residual or skin
recurrent disease.  Associated with increased
cholesterol LDL, apoB &
*Serum Calcitonin Test – tumor marker for increased risk of coronary disease
detecting residual thyroid metastasis in
medullary thyroid carcinoma (MTC)  Myxedema
 Worsen hypothyroidism
 TANNED ERYTHROCYTE  Described as peculiar nonpitting
HEMAGGLUTINATION MTD swelling of the skin, puffy
 Test for antithyroglobulin antibodies. appearance of the face especially
around the eyes
 Skin is dry has a yellowish color,
REMEMBER: body hair is lost, scalp hair often
 Free T4 and TSH are the best becomes dry and coarse
indicator of thyroid status  Progressive mental deterioration
 Free T3 and T4 are more specific  Atherosclerosis is accelerated
indicators of thyroid function than the due to accumulation of TAG &
measurements of total hormone CHOLE
because the values are not affected *Anemia – normocytic
by the TBG amount normochromic
 Patients with increased T4 binding  Congenital Hypothyroidism /
protein have an elevated T3 or T4 Cretinism
but not free T4 or TSH  Caused by hormone dysgenesis
 Puffy face, open mouth with
THYROID DISORDERS AND CLINICAL enlarged protruding tongue,
CORRELATIONS hoarse cy, short thick neck,
narrow forehead, pug nose,
 Hypothyroidism – insufficient levels short legs, distended abdomen,
of thyroid hormones to provide hirsutism & lethargy, mental
metabolic needs at cellular level retardation if treatment is not
 Affects four times more than done
female  TT4 is the primary screening
 Slows down metabolic process test, TSH is confirmatory &
 Symptoms: enlargement of the detects TBG deficiency.
thyroid (goiter), impairment of
cognition, fatigue, slowing of
Ge  Clinical Hypothyroidism (primary
 ACQUIRED HYPOTHYROIDISM or secondary) – decreased s-TSH,
 Inadequacy of hormone due to TT4, FT4, TRH to differentiate
damaged thyroid gland secondary to tertiary
 Due to: chronic thyroiditis,
surgical or radioactive iodine  HYPERTHYROIDISM
treatment of hyperthyroidism,  Thyrotoxicosis – is a group of
goiter, or cancer, idiopathic syndromes caused by high
atrophy, and other proliferative levels of free thyroid hormones.
disorder.  Symptoms include nervousness,
irritability, insomnia, fine tremor,
 CHRONIC AUTOIMMUNE excessive sweating, heat
THYROIDITIS (HASHIMOTO’S intolerance, flushed face, pruritis,
DISEASE) tachycardia, palpations, frequent
 Most common cause of primary bowel movements, hyperkinesis,
hypothyroidism (unidentified gynecomastia, oligomenorrhea to
abnormality in the immune amenorrhea, decreased libido,
system) loss of muscle mass, decreased
 The patient is either euthyroid or cholesterol, tendency towards
hypothyroid ketosis.
 There is a massive infiltration of
thyroid by lymphocytes
 Plasma cells are abundant &
increased amount of connective
tissue

 SUBCLINICAL HYPOTHYROIDISM
 Mild elevation of TSH with normal
T4, T3 and FT4
 May result to adjustment from NTI
or pregnancy

LABORATORY EVALUATION

 TSH Concentration – primary


hypothyroidism
 Progression: decreased FT4I, FT4,
TT4, TT3, rT3
 Thyroid TPO and antithyroid
antibodies can rule out autoimmune
disease
 THYROID STORM
 Known as thyrotoxic crisis – a life
threatening complication with
fever & tachycardia & neurologic
changes

CAUSES OF THYROTOXICOSIS
1. Increased RAIU – grave’s disease,
toxic multinodular goiter, TSH
secreting tumor, trophoblastic tumor &
toxic adenoma
2. Decreased RAIU – subacute
thyroiditis, chronic thyroiditis,
metastatic thyroid carcinoma

 EUTHYROID SICK
 Results from inactivation of 5’-
Deiodinase resulting in
conversion of FT4 or rT3
 Generally occurs in critically ill
patients but may occur with DM,
malnutrition, iodine loads, or
medications (Amiodarone, PTU,
glucocorticoids)
 Treatment
- Avoid above medication
- Treat primary illness
- T2, T4 not helpful

S-ar putea să vă placă și